Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2016-06-02 Major Shareholding Noti…
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2016
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding for an individual ('Anders Lönner') in Karo Healthcare AB. It explicitly states the 'Reason for major shareholding notification' and shows the 'Before the transaction' and 'After the transaction' share quantities and resulting percentages (5.28%). This structure is characteristic of a notification regarding a change in significant ownership, which aligns with the definition for Major Shareholding Notification (MRQ). The document is not a full annual report (10-K), an earnings release (ER), or a director's dealing report (DIRS), but specifically tracks the crossing of a shareholding threshold.
2016-06-02 English
Change of the number of shares and votes in Karo Pharma
Share Issue/Capital Change Classification · 98% confidence The document is a short press release dated May 31, 2016, announcing a 'Change of the number of shares and votes in Karo Pharma'. It explicitly states the new total number of shares (63,907,194) resulting from recently completed share issues. This directly relates to changes in the company's capital structure or share count. Based on the definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category, as it covers announcements regarding new share issues. It is not an Earnings Release (ER), Interim Report (IR), or a general Regulatory Filing (RNS), as it fits a specific category.
2016-05-31 English
Ändring av antalet aktier och röster i Karo Pharma AB
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a short press release (1217 characters) dated May 31, 2016, titled 'Ändring av antalet aktier och röster i Karo Pharma AB' (Change in the number of shares and votes in Karo Pharma AB). It explicitly states the total number of shares and votes (63,907,194) and attributes the increase to recently completed new share issues ('nyemissionerna'). This directly relates to changes in the company's capital structure and share count. This aligns best with the 'Share Issue/Capital Change' definition (SHA), which covers new share issues and capital changes. It is not a full report, an earnings release, or a director's dealing.
2016-05-31 Swedish
Årsstämma 2016 i Karo Pharma AB (publ)
AGM Information Classification · 98% confidence The document is explicitly titled 'Årsstämma 2016 i Karo Pharma AB (publ)' which translates to 'Annual General Meeting 2016 in Karo Pharma AB (publ)'. The text details decisions made at this meeting, including the approval of financial statements, dividend decisions, election/re-election of board members (including the chairman), decisions on board remuneration, and authorization for future share issuance. These are core components of an Annual General Meeting (AGM) outcome announcement. Therefore, the classification should be AGM-R (AGM Information). The document is a press release summarizing the results, not the presentation materials themselves, but the content is directly about the AGM decisions.
2016-05-12 Swedish
Annual General Meeting 2016 in Karo Pharma AB (publ)
AGM Information Classification · 98% confidence The document is explicitly titled 'Annual General Meeting 2016 in Karo Pharma AB (publ)' and details the resolutions passed at the AGM, such as adopting financial statements, electing the board, setting fees, and authorizing share issues. This content directly corresponds to the definition of 'AGM Information'. The document is a summary of the meeting outcomes, not a full proxy statement (PSI) or a general regulatory filing (RNS).
2016-05-12 English
Interim / Quarterly Report 2016
Interim / Quarterly Report Classification · 100% confidence The document is titled 'DELÅRSRAPPORT JANUARI – MARS 2016' (Interim Report January-March 2016). It contains comprehensive financial statements, including the income statement, balance sheet, cash flow statement, and changes in equity for the first quarter of 2016. It also includes management commentary, risk disclosures, and accounting principles. As it provides substantive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2016
2016-05-12 Swedish

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.